Dar Al-Shifa Pharmaceuticals Company reported unaudited preliminary earnings results for the full year ended December 31, 2014. For the year, net profit after tax reached $1,746,987, compared with a net profit after tax of $2,117,685 in the audited data for 2013, a net decrease of 17.5%.